Increasing Academic and Commercial R&D Spending on Pharmaceuticals
The pharmaceutical industry holds the largest share in the chromatography reagents market, hence, the fluctuations in the pharmaceutical industry, globally, directly affects the demand for chromatography reagents. In this industry, chromatography reagents are used for a wide variety of applications, including separation of chemical and biomolecules, for drug delivery, protein purification, diagnostics etc. With the number of diseases on the rise, increased AIDS and cancer research, and discovery of new viruses & bacteria, industries have called for development of newer molecular entities (NMEs) to combat these diseases, and have increased their R&D spending on medicines. With the rise of critical diseases globally, monoclonal antibody therapeutics is quickly gaining importance, which directly employs chromatography reagents.
Food & Beverages Industry to Dominate the Market Growth
Chromatography reagents are widely used in the food & beverages industry, for efficient purification of crystalline sugar and liquid sugar syrup. These reagents remove salt ions from the raw solutions and adsorb the yellowish-brown substances that give raw sugar its natural color. Further, the acidic ion exchange chromatography reagents charged with hydrogen ions are excellent catalysts for the mild hydrolysis of oligosaccharides and polysaccharides. The process results, for example, in a mixture of the monosaccharides glucose and fructose, which is used as a syrup in industrial applications. Ion exchange chromatography reagents can also simply and efficiently remove unwanted ionic compounds, such as, hardening elements or table salt, from gelatin, pectin, and whey. Combinations of strongly acidic, gelled and weakly-basic chromatography reagents generally are used for this purpose. The chromatography reagents are certified in many countries, worldwide for the processing of foods and drinking water. North America is currently the leader, in terms of consumption of chromatography reagents in the food & beverages industry. There are a large number of R&D activities, currently, in the United States, in the field of food purification, which is driving the market in the region.
North America Dominated the Market
The United States accounted for a lion’s share of the consumption in the North American region. The United States pharmaceutical industry was worth more than USD 450 billion in 2016. The industry is growing at a rapid rate. The aging population, rise in healthcare expenditure, along with increasing diseases has led to a significant growth in the pharmaceutical industry in the country. Healthcare is the largest expenditure in the US budget. About 20% of the total industry revenue is spent on R&D. The rising demand for monoclonal antibodies, due to the rising number of critical diseases in the country, has increased the market for chromatographic resin in the region.
Major Players: Merck KGaA, Bio-Rad Laboratories, Inc., Mitsubishi Chemical Corporation, Thermo Fisher Scientific Inc., Tosoh Corporation, and General Electric, amongst others.
Reasons to Purchase the Report
- The impact of increasing expenditure on academic and commercial R&D in pharmaceuticals will drive the market
- Analyzing various perspectives of the market with the help of Porter’s five forces analysis
- The type and technology that is expected to dominate the market
- The physical state of mobile phase and application that are expected to dominate the market
- The region that is expected to witness the fastest growth during the forecast period
- Identify the latest developments, market shares, and strategies employed by the major market players
- 3 months analyst support, along with the Market Estimation sheet in excel
This report can be customized to meet your requirements. Please contact us for more information.
1.1 Research Phases
1.2 Scope of the Report
1.3 Study Deliverables
2. Executive Summary
3. Market Insights
3.1 Industry Value Chain Analysis
3.2 Industry Attractiveness – Porter’s Five Forces Analysis
3.2.1 Bargaining Power of Suppliers
3.2.2 Bargaining Power of Buyers
3.2.3 Threat of New Entrants
3.2.4 Threat of Substitute Products and Services
3.2.5 Degree of Competition within the Industry
4. Market Dynamics
4.1.1 Increasing Academic and Commercial R&D Spending on Pharmaceuticals
4.1.2 Technological Advancements in Chromatography Reagents
4.1.3 Growing Importance of Chromatography Tests in Drug Approvals
4.2.1 Increasing Importance of Chromatography Tests in Drug Approvals
4.2.2 High Costs vs. Productivity of Chromatography Systems
4.3.1 Investments in Emerging Economies of Asia-Pacific
4.3.2 Rising Importance of Green Chromatography
5. Market Segmentation and Analysis (Market Size, Growth, and Forecast)
5.1 By Type
5.1.2 Ion Pair Reagents
5.1.4 Silylation Reagents
5.1.5 Alkylation and Esterification Reagents
5.1.6 Acylation Reagents
5.1.7 Solid Support
5.2 By Bed-shape
5.2.3 Thin Layer
5.3 By Physical State of Mobile Phase
5.3.1 Gas Chromatography Reagents
5.3.2 Liquid Chromatography Reagents
5.3.3 High Pressure Liquid Chromatography (HPLC) Reagents
5.3.4 Ultra High Pressure Liquid Chromatography (UHPLC) Reagents
5.3.5 Low Pressure Liquid Chromatography (LPLC) Reagents
5.3.6 Super Critical Fluid Chromatography (SFC) Reagents
5.4 By Technology
5.4.1 Ion Exchange
5.4.2 Affinity Exchange
5.4.3 Size Exclusion
5.4.4 Hydrophobic Interaction
5.5 By Application
18.104.22.168 Drug Discovery
22.214.171.124 Drug Production
5.5.2 Food & Beverages
5.5.3 Water & Environmental Analysis
6. Regional Market Analysis (Market Size, Growth, and Forecast)
6.1.4 South Korea
6.1.5 Rest of Asia-Pacific
6.2.2 United Kingdom
6.2.6 Rest of Europe
6.3 North America
6.3.1 United States
6.3.4 Rest of North America
6.4 Rest of the World
7. Competitive Landscape
7.1 Mergers & Acquisitions, Joint Ventures, Collaborations and Agreements
7.2 Market Share Analysis**
7.3 Strategies Adopted by Leading Players
8. Company Profiles (Overview, Financials**, Products & Services, Recent Developments, and Analyst View)
8.1 Agilent Technologies
8.2 Avantor Performance Materials, LLC
8.3 Bio-Rad Laboratories, Inc.
8.4 GENERAL ELECTRIC
8.5 Kanto Kagaku Singapore Pte Ltd
8.6 LobaChemie Pvt. Ltd
8.7 Merck KGaA
8.8 Mitsubishi Chemical Corporation
8.9 Regis Technologies, Inc.
8.10 Santa Cruz Biotechnology, Inc.
8.11 Thermo Fisher Scientific Inc.
8.12 Tosoh Corporation
*(List Not Exhaustive)
**Subject to availability on public domain
- Agilent Technologies
- Avantor Performance Materials LLC
- Bio-Rad Laboratories Inc.
- GENERAL ELECTRIC
- Kanto Kagaku Singapore Pte Ltd
- LobaChemie Pvt. Ltd
- Merck KGaA
- Mitsubishi Chemical Corporation
- Regis Technologies Inc.
- Santa Cruz Biotechnology Inc.
- Thermo Fisher Scientific Inc.
- Tosoh Corporation